Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARγ/STAT5 signaling pathway in macaques
Stéphane Prost, … , Isabelle Dusanter-Fourt, Marek Kirszenbaum
Stéphane Prost, … , Isabelle Dusanter-Fourt, Marek Kirszenbaum
Published April 22, 2008
Citation Information: J Clin Invest. 2008;118(5):1765-1775. https://doi.org/10.1172/JCI33037.
View: Text | PDF
Research Article

Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARγ/STAT5 signaling pathway in macaques

  • Text
  • PDF
Abstract

Infection of primates by HIV-1 and SIV induces multiple hematological abnormalities of central hematopoietic origin. Although these defects greatly contribute to the pathophysiology of HIV-1 infection, the molecular basis for altered BM function remains unknown. Here we show that when cynomolgus macaques were infected with SIV, the multipotent potential of their hematopoietic progenitor cells was lost, and this correlated with downregulation of STAT5A and STAT5B expression. However, forced expression of STAT5B entirely rescued the multipotent potential of the hematopoietic progenitor cells. In addition, an accessory viral protein required for efficient SIV and HIV replication and pathogenicity, “Negative factor” (Nef), was essential for SIV-mediated impairment of the multipotent potential of hematopoietic progenitors ex vivo and in vivo. This newly uncovered property of Nef was both conserved between HIV-1 and SIV strains and entirely dependent upon the presence of PPARγ in targeted cells. Further, PPARγ agonists mimicked Nef activity by inhibiting STAT5A and STAT5B expression and hampering the functionality of hematopoietic progenitors both ex vivo and in vivo. These findings have extended the role of Nef in the pathogenicity of HIV-1 and SIV and reveal a pivotal role for the PPARγ/STAT5 pathway in the regulation of early hematopoiesis. This study may provide a basis for investigating the potential therapeutic benefits of PPARγ antagonists in both patients with AIDS and individuals with hematopoietic disorders.

Authors

Stéphane Prost, Mikael Le Dantec, Sylvie Augé, Roger Le Grand, Sonia Derdouch, Gwenaelle Auregan, Nicole Déglon, Francis Relouzat, Anne-Marie Aubertin, Bernard Maillere, Isabelle Dusanter-Fourt, Marek Kirszenbaum

×

Figure 1

SIV inhibits the clonogenic potential of hematopoietic progenitors through downregulation of STAT5.

Options: View larger image (or click on image) Download as PowerPoint
SIV inhibits the clonogenic potential of hematopoietic progenitors throu...
(A) Evaluation of total progenitor cell counts in semisolid cultures of CD34+ BM cells collected from 5 animals before and after infection with SIV. Day 0 is the day of SIV injection. Horizontal lines indicate mean CFC numbers scored from all cell cultures from the 5 animals analyzed at the indicated time. Each symbol represents samples from a single animal. (B) STAT5B mRNA was evaluated by RT-PCR in CD34+ BM cells at various times following animal infection with SIV. Levels were normalized to GAPDH mRNA. Results were expressed relative to the average level of STAT5B mRNA in samples collected before SIV injection. Horizontal lines indicate the mean values for STAT5B mRNA in 5 animal samples at the indicated time. STAT5A mRNA was similarly evaluated and compared in noninfected control (NI) and chronically SIV-infected animals (SIV) (inset). (C) CD34+ BM cells from 3 noninfected control and 3 SIVmac251-infected macaques at 93 days after injection were lysed. Lysates were subjected to SDS-PAGE and western blotting. STAT5 and actin proteins were detected by coincubation with pan STAT5 and anti-actin antibodies. (D) CD34+ BM cells from 4 control or 4 chronically SIV-infected macaques were transduced with or without a lentiviral vector encoding simian STAT5B. They were processed for CFC assays. Experiments were repeated twice. Horizontal lines indicate the mean number of colonies scored in each condition. Each symbol represents samples from a single animal.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts